Ref: Blakeway,L.V. et al. FASEB J. (2014) In press

REBASE ref # 18392

Complete sequence: 1,887,974 bp

GenBank #: CP007669

REBASE acronym: Mca25239

Org_num: 13888

 

All begin MC25239_

Type I
ORF Gene Most similar Specificity Name
 
66 CRISPR-associated helicase Cas3, subtype
67 M M.Mca353ORF290P (100% identity) CAAGNNNNNNTGT M.Mca25239II
68 S S.Mca353ORF290P (100% identity) CAAGNNNNNNTGT S.Mca25239II
69 359 aa hypothetical protein
70 163 aa hypothetical protein
71 R Mca353ORF290P (99% identity) CAAGNNNNNNTGT Mca25239IIP
72 232 aa hypothetical protein
 
1738 106 aa hypothetical protein
??? S S.Mca202156ORFAP (100% identity) S.Mca25239ORF1739P
1740 295 aa hypothetical protein
Type II
ORF Gene Most similar Specificity Name
 
16 Anhydro-N-acetylmuramic acid kinase
17 M M.McaRHORF1876P (100% identity) GCNGC M.Mca25239ORF17P
18 R McaRHORF1876P (100% identity) GCNGC Mca25239ORF17P
19 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
 
527 Valine--tRNA ligase
528 M M1.McaRHORF518P (100% identity) GATC M1.Mca25239ORF528P
529 R Mov11969ORF1694P (100% identity) GATC Mca25239ORF528P
530 56 aa hypothetical protein
531 M M2.McaRHORF518P (100% identity) GATC M2.Mca25239ORF528P
532 Acetoin utilization protein AcuC
 
1098 pseudogene
1100 R Mca25240MrrP (100% identity) Mca25239MrrP
1101 Carbamoyl-phosphate synthase small chain
 
1707 Phosphatidylglycerophosphatase A
1708 M M.Mca43617ORFKP (81% identity) M1.Mca25239ORF1708P
1709 M M2.McaRH4ORF1866P (99% identity) M2.Mca25239ORF1708P
1711 39 aa hypothetical protein
1712 R McaMC6ORF850P (22% identity) R1.Mca25239ORF1708P
1713 R Mca87B1ORF1938P (68% identity) R2.Mca25239ORF1708P
1714 Heat shock protein 33
Type III
ORF Gene Most similar Specificity Name
 
379 Diaminobutyrate--2-oxoglutarate
380 M M.McaMC5ORF1675P (97% identity) GARAC M.Mca25239I
381 R Mca353ORF4840P (100% identity) GARAC Mca25239IP
382 L-2,4-diaminobutyrate decarboxylase
Tech Support Feedback NEB Overview Site Map Trademarks Legal and Disclaimers Privacy Cookie Policy Terms of Use
© Copyright 2023 New England Biolabs. All Rights Reserved.